The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry

T. Meischl (Vienna, Austria), K. Schmid-Scherzer (Vienna, Austria), J. Loeffler-Ragg (Innsbruck, Austria), F. Grabcanovic-Musija (Salzburg, Austria), S. Mueller (Hohenems, Austria), G. Wurzinger (Gratwein-Strassengel, Austria), N. Kaufmann (Graz, Austria), M. Rauter (Klagenfurt, Austria), A. Valipour (Vienna, Austria), G. Funk (Vienna, Austria)

Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Session: What's new in respiratory problems in rare and systemic diseases
Session type: E-poster
Number: 3302

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Meischl (Vienna, Austria), K. Schmid-Scherzer (Vienna, Austria), J. Loeffler-Ragg (Innsbruck, Austria), F. Grabcanovic-Musija (Salzburg, Austria), S. Mueller (Hohenems, Austria), G. Wurzinger (Gratwein-Strassengel, Austria), N. Kaufmann (Graz, Austria), M. Rauter (Klagenfurt, Austria), A. Valipour (Vienna, Austria), G. Funk (Vienna, Austria). The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry. 3302

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Lung clearance index in alpha-1-antitrypsin deficiency - A follow up
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013


Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Lung transplantation in alpha 1 antitrypsin deficiency
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

Late Breaking Abstract - Impact of COVID-19 on patients with severe alpha1 antitrypsin deficiency: the IMCA1 study of the EARCO ERS Clinical Research Collaboration, preliminary findings.
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population - results from large scale newborn screening
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency
Source: Eur Respir J, 53 (2) 1900138; 10.1183/13993003.00138-2019
Year: 2019



Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015


Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021

Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Does bronchial location of lung cancer influence overall survival?
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015